
Glimtos MP 2mg/500mg/15mg Tablet
Marketer
Medcure Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimtos MP 2mg/500mg/15mg Tablet
Metformin/Pioglitazone/Voglibose 2mg/500mg/15mg tablets are a triple-action medication designed to manage blood glucose. This combined therapy, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness and consequently reduces blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Always take this medication with food to mitigate potential gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Overdosage can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or missed meals increases the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing this medication, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating women must consult their physician before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it can elevate the risk of side effects.
Uses of Glimtos MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimtos MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimtos MP 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimtos MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimtos MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimtos MP 2mg/500mg/15mg tablet whole; do not crush, chew, or break it. Administer this medication with food.
How Glimtos MP 2mg/500mg/15mg Tablet works:
Glimtos MP 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination effectively manages blood glucose when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, lowers hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimtos MP 2mg/500mg/15mg Tablet with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimtos MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against the risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimtos MP 2mg/500mg/15mg tablets while breastfeeding is likely unsafe. Available data from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimtos MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtos MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimtos MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimtos MP 2mg/500mg/15mg Tablet :
Should you forget to take a Glimtos MP 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimtos MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
